Most cited papers from Abbott (United States)

Abbott (United States)

What are the most cited papers from Abbott (United States)?

The most cited paper from Abbott (United States) is "2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative" (Daniel Aletaha et al., 2010), with 9,731 citations. Next come "Enzymatic Determination of Total Serum Cholesterol" (9,199) and "HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time" (3,587).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 730 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative Daniel Aletaha et al. · Arthritis & Rheumatism Open access	10 Aug 2010	9,731
2	Enzymatic Determination of Total Serum Cholesterol Charles C. Allain, Lucy S Poon, Cicely S G Chan et al. · Clinical Chemistry Open access	Apr 1974	9,199
3	HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time Alan S. Perelson, Avidan Uriel Neumann, Martin H. Markowitz et al. · Science	15 Mar 1996	3,587
4	Membrane transporters in drug development Kathleen M. Giacomini et al. · Nature Reviews Drug Discovery ReviewOpen access	Mar 2010	3,373
5	A Prospective Natural-History Study of Coronary Atherosclerosis Gregg W. Stone, Akiko Maehara, Alexandra J. Lansky et al. · New England Journal of Medicine Open access	19 Jan 2011	3,303
6	CRISPR–Cas12-based detection of SARS-CoV-2 James P. Broughton, Xianding Deng, Guixia Yu et al. · Nature Biotechnology Open access	16 Apr 2020	2,889
7	The Colorado Thyroid Disease Prevalence Study Gay J. Canaris, Neil Manowitz, Gilbert H. Mayor et al. · Archives of Internal Medicine	28 Feb 2000	2,848
8	High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Daniel Pinkel, Richard Segraves, Damir Sudar et al. · Nature Genetics	Oct 1998	2,262
9	Discovering High-Affinity Ligands for Proteins: SAR by NMR Suzanne Beckham Shuker, Philip J. Hajduk, Robert P. Meadows et al. · Science	29 Nov 1996	2,061
10	The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism	29 Dec 2005	1,794
11	Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial Michael E. Weinblatt, Edward Clark Keystone, Daniel E. Furst et al. · Arthritis & Rheumatism	2003	1,767
12	Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial Stephen B. Hanauer, William J. Sandborn, Paul J. Rutgeerts et al. · Gastroenterology	Feb 2006	1,727
13	Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women Paul M. Ridker, Julie E. Buring, Jessie Shih et al. · Circulation Open access	25 Aug 1998	1,654
14	Tumor necrosis factor antagonist mechanisms of action: A comprehensive review Daniel E. Tracey, Lars Klareskog, Eric H. Sasso et al. · Pharmacology & Therapeutics	14 Nov 2007	1,636
15	Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction Stefan Hans Hohnloser, Karl Heinz Kuck, Paul Dorian et al. · New England Journal of Medicine	9 Dec 2004	1,528
16	X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death Steven W. Muchmore, Michael Sattler, Heng Liang et al. · Nature	May 1996	1,475
17	A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report Mandeep R. Mehra et al. · New England Journal of Medicine Open access	17 Mar 2019	1,314
18	Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology	5 Nov 2011	1,274
19	Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial Edward Clark Keystone, Arthur F. Kavanaugh, John Turner Sharp et al. · Arthritis & Rheumatism	May 2004	1,176
20	Isolation of novel virus-like sequences associated with human hepatitis John N. Simons, Thomas P. Leary, George J. Dawson et al. · Nature Medicine	Jun 1995	1,148
21	Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis Michael R. Wilson et al. · New England Journal of Medicine Open access	12 Jun 2019	1,093
22	Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions Judith Hall, Toni D. Uhrich, Jill A. Barney et al. · Anesthesia & Analgesia	Mar 2000	1,083
23	Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease Gregg W. Stone et al. · New England Journal of Medicine Open access	31 Oct 2016	1,069
24	A decade of fragment-based drug design: strategic advances and lessons learned Philip J. Hajduk, Jonathan Greer · Nature Reviews Drug Discovery Review	9 Feb 2007	1,068
25	Ritonavir: An Extraordinary Example of Conformational Polymorphism John F. Bauer, Stephen G. Spanton, Rodger F. Henry et al. · Pharmaceutical Research	Jun 2001	1,068
26	Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial William J. Sandborn, Stephen B. Hanauer, Paul Rutgeerts et al. · Gut Open access	13 Feb 2007	1,043
27	Actionable Diagnosis of Neuroleptospirosis by Next-Generation Sequencing Michael R. Wilson et al. · New England Journal of Medicine Open access	4 Jun 2014	1,043
28	A Bioavailability Score Yvonne Connolly Martin · Journal of Medicinal Chemistry	5 Apr 2005	1,032
29	Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions Antonio Hugo Bezerra Colombo, Janusz Drzewiecki, Adrian Banning et al. · Circulation Open access	4 Aug 2003	1,022
30	Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure Alexandre Mebazaa, Markku S. Nieminen, Milton Packer et al. · JAMA	May 2007	995
31	The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Leming M. Shi et al. · Nature Biotechnology Open access201 authors	30 Jul 2010	922
32	Transcatheter Repair for Patients with Tricuspid Regurgitation Paul Sorajja et al. · New England Journal of Medicine	4 Mar 2023	914
33	Modular Organization of Genes Required for Complex Polyketide Biosynthesis Stefano Donadio, Michael J. Staver, James B. McAlpine et al. · Science	3 May 1991	914
34	Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease Gregg W. Stone, Ali Abbas Rizvi, William N. Newman et al. · New England Journal of Medicine Open access	5 May 2010	901
35	Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial Walter Reinisch, William J. Sandborn, Daniël W. Hommes et al. · Gut Open access	5 Jan 2011	894
36	Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial Alan Menter, Stephen Keith Tyring, Kenneth B. Gordon et al. · Journal of the American Academy of Dermatology	3 Dec 2007	892
37	Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Désirée M F M van der Heijde, Alan Kivitz, Michael H. Schiff et al. · Arthritis & Rheumatism	26 Jun 2006	882
38	Ferricytochrome c Richard E. Dickerson, Tsunehiro Takano, David S Eisenberg et al. · Journal of Biological Chemistry Open access	Mar 1971	878
39	Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity Wyndham Hopkins Wilson, Owen A. O’Connor, Myron Stefan Czuczman et al. · The Lancet Oncology Open access	20 Nov 2010	873
40	In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients With Acute Coronary Syndrome by Intravascular Optical Coherence Tomography Haibo Jia et al. · Journal of the American College of Cardiology Open access	27 Jun 2013	858
41	Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes Heléne Norder, Anne‐Marie Couroucé, Pierre Coursaget et al. · Intervirology	2004	839
42	Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease Andrew Warwick Roberts, John Francis Seymour, Jennifer R. Brown et al. · Journal of Clinical Oncology Open access	20 Dec 2011	831
43	Isoforms of nitric oxide synthase Characterization and purification from different cell types Ulrich Förstermann, Harald H.H.W. Schmidt, Jennifer S. Pollock et al. · Biochemical Pharmacology	Oct 1991	825
44	A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Patrick W.J.C. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet	Mar 2009	821
45	Bcl-xL forms an ion channel in synthetic lipid membranes Andy J. Minn, Patricio Vélez, Sharon L. Schendel et al. · Nature	1997	819
46	Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease Gregg W. Stone et al. · New England Journal of Medicine Open access	28 Sep 2019	803
47	The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia Herbert Lepor, William O. Williford, Michael J. Barry et al. · New England Journal of Medicine Open access	22 Aug 1996	801
48	Structural Basis for the Inhibition of Caspase-3 by XIAP Stefan J. Riedl, Martin Renatus, Robert Schwarzenbacher et al. · Cell Open access	Mar 2001	793
49	THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE Thorir D. Bjornsson et al. · Drug Metabolism and Disposition	18 Jun 2003	792
50	Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Kenneth C.H. Fearon, Anne Coble Voss, Deborah S. Hustead · American Journal of Clinical Nutrition Open access	Jun 2006	786

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.